Classes
Publications
- Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy2025 | Faculty of Medicine in Hradec Králové
- International Journal of Nanomedicine Human primary monocytes as a model for in vitro immunotoxicity testing: Evaluation of the regulatory properties of TiO2 nanoparticles2025 | Faculty of Medicine in Hradec Králové
- Uhlíkové nanomateriály: biomedicínské aplikace a toxicita2025 | Faculty of Medicine in Hradec Králové
- Scientific Reports Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration2024 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- The differences in the count of B lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in healthy subjects in pollen season and out of pollen season2024 | Faculty of Medicine in Hradec Králové
- The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy2024 | Faculty of Medicine in Hradec Králové
- The Influence of Metabolic Syndrome on Potential Aging Biomarkers in Participants with Metabolic Syndrome Compared to Healthy Controls2024 | Faculty of Medicine in Hradec Králové
- The association between expression of CD200 on B lymphocytes and the count of eosinophils and basophils in atopic dermatitis patients with and without dupilumab therapy - Pilot study2024 | Faculty of Medicine in Hradec Králové
- Characterizing of intra-amniotic inflammatory changes associated with chronic inflammation in the placenta marked by elevated amniotic fluid interferon gamma-induced protein 10 (IP-10) in pregnancies complicated by preterm prelabor rupture of membranes2024 | Faculty of Medicine in Hradec Králové
- Absolute counts of leukocyte subsets in peripheral blood in pregnancies complicated by preterm prelabour rupture of membranes2024 | Faculty of Medicine in Hradec Králové
Loading network view...
